Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: A randomised trial (European Journal of Endocrinology 167 (287-294))

Research output: Contribution to journalComment/debateResearchpeer-review

DOI

  1. Risk of over- And under- treatment with levothyroxine in primary care in Copenhagen, Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience

    Research output: Contribution to journalReviewResearchpeer-review

  4. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. SGLT2 inhibitors: Clinical benefits by restoration of normal diurnal metabolism?

    Research output: Contribution to journalReviewResearchpeer-review

  • Leo Niskanen
  • Lawrence A. Leiter
  • Edward Franek
  • Jianping Weng
  • Taner Damci
  • Manuel Muñoz-Torres
  • Jean Paul Donnet
  • Lars Endahl
  • Trine Vang Skjøth
  • Allan Vaag
View graph of relations
Original languageEnglish
JournalEuropean Journal of Endocrinology
Volume167
Issue number3
Number of pages1
ISSN0804-4643
DOIs
Publication statusPublished - 1 Sep 2012

ID: 59278319